Genky DrugStoresGenky DrugStores Co., Ltd.9267東証プライム小売業FY ending Jun 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥5 is left as operating profit. Revenue changed +9.9% from the prior year, operating profit +13.7%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 2.9% | 1.59× | 4.6% | 2.68× | 12.2% |
| 2023 | 2.8% | 1.67× | 4.7% | 2.65× | 12.4% |
| 2024 | 3.4% | 1.68× | 5.8% | 2.52× | 14.5% |
| 2025 | 3.5% | 1.66× | 5.9% | 2.42× | 14.2% |
| 2026 | 3.6% | 1.62× | 5.8% | 2.39× | 13.8% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Jun 2022 | FY ending Jun 2023 | FY ending Jun 2024 | FY ending Jun 2025 | FY ending Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 154,639 | 169,059 | 184,860 | 200,786 | 220,638 |
| Cost of revenue | 123,685 | 134,505 | 147,239 | 159,896 | 175,715 |
| Gross profit | 30,954 | 34,553 | 37,620 | 40,889 | 44,923 |
| SG&A | 25,279 | 27,844 | 28,605 | 31,231 | 33,938 |
| Operating income | 5,675 | 6,709 | 9,015 | 9,658 | 10,985 |
| Pretax income | 6,083 | 6,704 | 8,803 | 9,902 | 11,153 |
| Income tax | 1,663 | 1,939 | 2,478 | 2,836 | 3,277 |
| Net income attributable to owners | 4,420 | 4,764 | 6,324 | 7,066 | 7,875 |
| Operating margin | 3.7% | 4.0% | 4.9% | 4.8% | 5.0% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Jun 2022 | FY ending Jun 2023 | FY ending Jun 2024 | FY ending Jun 2025 | FY ending Jun 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥5.44B | ¥5.33B | ¥5.9B | ¥6.22B | ¥7.87B |
| Total assets | ¥97.1B | ¥105.9B | ¥113.9B | ¥127.3B | ¥145.6B |
| Net assets | ¥36.2B | ¥40.7B | ¥46.7B | ¥53.4B | ¥61.4B |
| Share capital | ¥1.01B | ¥1.01B | ¥1.02B | ¥1.03B | ¥1.08B |
| Property, plant and equipment | ¥59.3B | ¥65.1B | ¥69.9B | ¥79.2B | ¥91.9B |
| Intangible assets excluding goodwill | ¥374M | ¥363M | ¥378M | ¥307M | ¥266M |
| Investment securities | ¥28M | ¥73M | ¥66M | ¥62M | ¥90M |
| Current assets | ¥31.5B | ¥34.4B | ¥37.3B | ¥41.2B | ¥46.1B |
| Current liabilities | ¥37.6B | ¥40.1B | ¥40.8B | ¥43.8B | ¥49.7B |
| Long-term borrowings | ¥20.8B | ¥20.9B | ¥22.4B | ¥25.8B | ¥30B |
| Total liabilities | ¥60.9B | ¥65.2B | ¥67.3B | ¥73.9B | ¥84.2B |
| Equity attributable to owners of parent | ¥36.2B | ¥40.6B | ¥46.5B | ¥53.2B | ¥61.1B |
| Retained earnings | ¥29.5B | ¥33.9B | ¥39.9B | ¥46.5B | ¥54B |
| Treasury stock | -¥789M | -¥789M | -¥790M | -¥790M | -¥699M |
EDINET (FSA Japan)
有価証券報告書－第9期(2025/06/21－2026/06/20)
EDINET (FSA Japan)
有価証券報告書－第8期(2024/06/21－2025/06/20)
EDINET (FSA Japan)
有価証券報告書－第7期(2023/06/21－2024/06/20)
EDINET (FSA Japan)
有価証券報告書－第6期(2022/06/21－2023/06/20)
EDINET (FSA Japan)
有価証券報告書－第5期(令和3年6月21日－令和4年6月20日)
EDINET (FSA Japan)
有価証券報告書－第4期(令和2年6月21日－令和3年6月20日)
Extracted from XBRL: 46 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.